课题基金 / 基金详情

Role of Peanut Allergen in Urban Schools and Preschools

Role of Peanut Allergen in Urban Schools and Preschools
花生过敏原在城市学校和幼儿园中的作用
批准号:
8897988
负责人:
William James Sheehan
金额:
$18.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2019-07-31

项目摘要

项目成果

William James Sheehan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal details a five-year plan to provide the candidate, William Sheehan, MD, with the knowledge and expertise to become an independent investigator in the field of Allergy and Immunology. The proposed research project is centered on a novel strategy of evaluating the amount of detectable environmental peanut protein exposure in childhood environments, such as homes, schools, and preschools. It has recently been theorized that avoidance of foods at a young age has contributed to the rise in food allergies, because children were instead becoming sensitized by cutaneous exposure to small amounts of food proteins in the environment. Dr. Sheehan presents preliminary data demonstrating detectable amounts of peanut protein (Ara h 2) in schools and homes. The candidate will use the established infrastructure of his mentor, Dr. Wanda Phipatanakul (current NIAID-funded study entitled School and Inner City Asthma Study); to further explore the study of peanut protein in the environment by analyzing vacuumed dust and table wipe samples. In addition to evaluating homes and schools, peanut-free preschools serving very young children will also be evaluated. Additionally, Dr. Sheehan will evaluate the effect of this environmental peanut exposure on health outcomes. Specifically, he will investigate the effect of exposure to environmental peanut protein on asthma morbidity with a particular focus on children considered to be at the highest risk of being affected by this cutaneous exposure. The "at risk" group will be defined by an enrolled subject with any one of the following conditions: (1) peanut allergy, (2) eczema, or (3) filaggrin gene mutation. Dr. Sheehan will work under the mentorship of Dr. Phipatanakul, an expert in environmental exposures and the relationship with allergic diseases. Dr. Sheehan has also assembled a team of extraordinary researchers, including Drs. Diane Gold, Raif Geha, and Brent Coull, who have committed their time, resources, and expertise to facilitate his career development and research goals. During the period of support for the candidate, he will engage in formal education on clinical research by obtaining a Master of Medical Sciences (MMSc) degree from the Scholars in Clinical Science Program at Harvard Medical School. This program will provide him with further skills in advanced biostatistics, epidemiology, clinical study design, clinical genetics, and scientific writing. Under the guidance of his primary mentor and collaborative team, in an ideal scientific and clinical environment at Boston Children's Hospital, the research project and career development plan will position the candidate to secure independent NIH funding and to establish himself as an independent clinical researcher in the field of environmental food exposures and allergic diseases, a relatively neglected area of investigation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
District of Columbia Childhood Asthma in Urban Settings - Clinical Research Center
  • 批准号:
    10588214
  • 项目类别:
  • 资助金额:
    $43.18万
  • 财政年份:
    2021
  • 负责人:
    William James Sheehan
  • 依托单位:
Role of Peanut Allergen in Urban Schools and Preschools
  • 批准号:
    8635611
  • 项目类别:
  • 资助金额:
    $18.3万
  • 财政年份:
    2014
  • 负责人:
    William James Sheehan
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: